Accelerating therapeutic discovery and enabling personalized medicine through the use of patient-derived cell models
Stem Cell Theranostics (SCT) is a biotechnology company dedicated to accelerating therapeutic discovery and enabling personalized medicine using patient-derived cell models.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 17, 2015 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |